Option Care Health Insider Buy: 750 Shares Purchased by Director

Rhea-AI Filing Summary

Pate R. Carter, a director of Option Care Health, Inc. (OPCH), reported purchasing 750 shares of the company's common stock on 08/20/2025 at a weighted average price of $27.1886 per share. After the reported purchase the filing shows the reporting person beneficially owns 41,910 shares. The transaction is coded "P" (purchase). The explanatory note states the 750 shares were bought in multiple transactions with prices ranging from $27.18 to $27.1899, and the reporter will provide detailed per-trade quantities and prices upon request. The Form 4 was signed on behalf of Mr. Carter by an attorney-in-fact.

Positive

• Director purchase disclosed with specific share count and weighted average price, meeting Form 4 disclosure requirements
• Post-transaction beneficial ownership is reported (41,910 shares), providing transparency
• Explanatory note details per-trade price range and offers to provide full per-trade information on request

Negative

• None.

Insights

Financial Analyst

TL;DR: Director purchased 750 shares, modest insider buy; no material change to ownership.

The filing documents a standard Section 16 purchase by a director: 750 shares acquired at a weighted average of $27.1886 on 08/20/2025, bringing beneficial ownership to 41,910 shares. This is a routine disclosure required under Form 4 and does not include derivative transactions or other material corporate actions. The transaction code "P" confirms an outright purchase; the explanatory footnote clarifies multiple trades at nearly identical prices. From a capital-markets perspective, the size of the purchase is small relative to institutional holdings and does not by itself indicate a material shift in control or ownership.

Corporate Governance Expert

TL;DR: Governance filing is complete and compliant; disclosure includes per-trade price range.

The Form 4 includes required elements: reporting person identity, relationship to issuer (Director), transaction date, transaction code (P), number of shares acquired, post-transaction beneficial ownership, and an explanatory note about price dispersion. The signature was provided by an attorney-in-fact, which is permissible. No amendments or derivative positions are reported. This appears to be a routine, compliant insider reporting event under Section 16.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pate R Carter

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		P		750	A	$27.1886(1)	41,910	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the weighted average price of 750 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $27.18 to $27.1899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

	/s/ Michael Shapiro, attorney-in-fact for Mr. Pate	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OPCH director Pate R. Carter report purchasing?

The director reported purchasing 750 shares of Option Care Health, Inc. common stock on 08/20/2025.

At what price were the OPCH shares purchased?

The weighted average purchase price was $27.1886 per share; individual trade prices ranged from $27.18 to $27.1899.

How many OPCH shares does the reporting person own after the transaction?

The filing shows the reporting person beneficially owns 41,910 shares following the reported purchase.

What transaction code is used on the Form 4 and what does it mean?

The transaction is coded "P", which denotes an outright purchase of shares.

Who signed the Form 4 for Pate R. Carter?

The Form 4 was signed on behalf of Mr. Carter by Michael Shapiro, attorney-in-fact on 08/21/2025.